Eric Benevich

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

NBIX

Current role

6 calls Latest call 2026-07-30

ATYR

Current role

Board Member

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$668,690	$463,000	$2,349,928	$2,349,995	—	$57,334	$5,888,947
2024	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$636,848	$366,188	$2,800,081	$2,449,932	—	$53,115	$6,306,164
2021	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$534,900	$213,960	$2,375,068	$2,625,019	—	$56,139	$5,805,086
2020	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$499,900	$199,960	$3,000,257	$2,999,869	—	$48,974	$6,748,960
2019	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$467,200	$280,320	$1,250,035	$3,750,345	—	$45,547	$5,793,447
2018	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$432,600	$205,485	$1,499,417	$1,496,335	—	$38,768	$3,672,605
2017	Neurocrine Biosciences Inc (NBIX)	Chief Commercial Officer	$410,000	$246,000	$458,344	$1,825,536	—	$37,722	$2,977,602

Earnings-call appearances and filed executive appointments or departures, newest first.